These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 9000600

  • 1. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
    Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D.
    Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600
    [Abstract] [Full Text] [Related]

  • 2. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
    Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW.
    Cancer Res; 1992 Feb 15; 52(4):797-802. PubMed ID: 1737339
    [Abstract] [Full Text] [Related]

  • 3. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
    Siegel D, McGuinness SM, Winski SL, Ross D.
    Pharmacogenetics; 1999 Feb 15; 9(1):113-21. PubMed ID: 10208650
    [Abstract] [Full Text] [Related]

  • 4. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
    Gasdaska PY, Fisher H, Powis G.
    Cancer Res; 1995 Jun 15; 55(12):2542-7. PubMed ID: 7780966
    [Abstract] [Full Text] [Related]

  • 5. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
    Takakuwa O, Oguri T, Ozasa H, Uemura T, Kunii E, Kasai D, Miyazaki M, Maeno K, Sato S.
    J Thorac Oncol; 2011 Nov 15; 6(11):1826-32. PubMed ID: 21964527
    [Abstract] [Full Text] [Related]

  • 6. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL, Hargreaves RH, Butler J, Ross D.
    Clin Cancer Res; 1998 Dec 15; 4(12):3083-8. PubMed ID: 9865924
    [Abstract] [Full Text] [Related]

  • 7. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
    Hu LT, Stamberg J, Pan S.
    Cancer Res; 1996 Nov 15; 56(22):5253-9. PubMed ID: 8912865
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and genetic analysis of NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Siegel D, Kepa JK, Ross D.
    Curr Protoc Toxicol; 2007 Nov 15; Chapter 4():Unit4.22. PubMed ID: 23045144
    [Abstract] [Full Text] [Related]

  • 9. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H, Bayram S, Bekar A, Akgöllü E, Ülger Y, Kaya BY, Sandikçi M, Özdil B.
    Asian Pac J Cancer Prev; 2010 Nov 15; 11(4):1051-8. PubMed ID: 21133623
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
    Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT.
    Blood; 1999 Jul 15; 94(2):803-7. PubMed ID: 10397748
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.
    Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC.
    Lung Cancer; 2001 Nov 15; 34(2):177-83. PubMed ID: 11679176
    [Abstract] [Full Text] [Related]

  • 12. Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.
    Beall HD, Hudnott AR, Winski S, Siegel D, Swann E, Ross D, Moody CJ.
    Bioorg Med Chem Lett; 1998 Mar 03; 8(5):545-8. PubMed ID: 9871615
    [Abstract] [Full Text] [Related]

  • 13. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
    Beall HD, Winski S, Swann E, Hudnott AR, Cotterill AS, O'Sullivan N, Green SJ, Bien R, Siegel D, Ross D, Moody CJ.
    J Med Chem; 1998 Nov 19; 41(24):4755-66. PubMed ID: 9822546
    [Abstract] [Full Text] [Related]

  • 14. Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.
    Pan SS, Han Y, Farabaugh P, Xia H.
    Pharmacogenetics; 2002 Aug 19; 12(6):479-88. PubMed ID: 12172217
    [Abstract] [Full Text] [Related]

  • 15. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
    Takagi S, Kinouchi Y, Hiwatashi N, Hirai M, Suzuki S, Takahashi S, Negoro K, Obana N, Shimosegawa T.
    Anticancer Res; 2002 Aug 19; 22(5):2749-52. PubMed ID: 12529991
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of NQO1 gene expression and variant allele in human NSCLC tumors and matched normal lung tissue.
    Kolesar JM, Pritchard SC, Kerr KM, Kim K, Nicolson MC, McLeod H.
    Int J Oncol; 2002 Nov 19; 21(5):1119-24. PubMed ID: 12370763
    [Abstract] [Full Text] [Related]

  • 17. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.
    Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM.
    Br J Cancer; 1995 Sep 19; 72(3):555-61. PubMed ID: 7669561
    [Abstract] [Full Text] [Related]

  • 18. Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1.
    Anwar A, Siegel D, Kepa JK, Ross D.
    J Biol Chem; 2002 Apr 19; 277(16):14060-7. PubMed ID: 11821413
    [Abstract] [Full Text] [Related]

  • 19. An association between a NQO1 genetic polymorphism and risk of lung cancer.
    Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X.
    Mutat Res; 2005 Apr 04; 582(1-2):71-8. PubMed ID: 15781212
    [Abstract] [Full Text] [Related]

  • 20. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
    Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD.
    Cancer Res; 1992 Sep 01; 52(17):4752-7. PubMed ID: 1324793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.